{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T02:29:18Z","timestamp":1781922558846,"version":"3.54.5"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T00:00:00Z","timestamp":1700179200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Several registries for hidradenitis suppurativa (HS) already exist in Europe and the USA. There is currently no global consensus on a core dataset (CDS) for these registries. Creating a global HS registry is challenging, owing to logistical and regulatory constraints, which could limit opportunities for global collaboration as a result of differences in the dataset collected. The solution is to encourage all HS registries to collect the same CDS of information, allowing registries to collaborate.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To establish a core set of items to be collected by all HS registries globally. The core set will cover demographic details, comorbidities, clinical examination findings, patient-reported outcome measures and treatments.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Beginning in September 2022, 20 participants \u2013 including both clinicians with expertise in HS and patient advocates \u2013 from eight countries across three continents participated in a Delphi process consisting of four rounds of voting, with all participants completing each round. A list of potential items for inclusion in the core set was generated from the relevant published literature, including systematic reviews of comorbidities in HS, clinical and examination findings, and epidemiology. For disease severity and progression items, the Hidradenitis SuppuraTiva Core outcome set International Collaboration (HiSTORIC) core set and other relevant instruments were considered for inclusion. This resulted in 47 initial items. Participants were invited to suggest additional items to include during the first round. Anonymous feedback was provided to inform each subsequent round of voting to encourage consensus.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The eDelphi process established a CDS of 48 items recommended for inclusion in all HS registries globally.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The routine adoption of this CDS in current and future HS registries should allow registries in different parts of the world to collaborate, enabling research requiring large numbers of participants.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/bjd\/ljad454","type":"journal-article","created":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T21:56:03Z","timestamp":1700085363000},"page":"510-518","source":"Crossref","is-referenced-by-count":4,"title":["Global consensus process to establish a core dataset for hidradenitis suppurativa registries"],"prefix":"10.1093","volume":"190","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4521-2907","authenticated-orcid":false,"given":"Hannah E","family":"Wainman","sequence":"first","affiliation":[{"name":"Department of Dermatology, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK"},{"name":"Bristol Medical School, University of Bristol , Bristol , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8225-0035","authenticated-orcid":false,"given":"Nisha S","family":"Chandran","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Department of Medicine, National University Hospital , Singapore"},{"name":"Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore , Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5042-3632","authenticated-orcid":false,"given":"John W","family":"Frew","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Liverpool Hospital , Sydney, NSW , Australia"},{"name":"University of New South Wales , Sydney, NSW , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0886-6856","authenticated-orcid":false,"given":"Amit","family":"Garg","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Donald and Barbara Zucker School of Medicine at Hofstra Northwell , New Hyde Park, NY , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Gibbons","sequence":"additional","affiliation":[{"name":"Patient Representative, The HS Support Network UK and Ireland , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5285-4954","authenticated-orcid":false,"given":"Athena","family":"Gierbolini","sequence":"additional","affiliation":[{"name":"Patient Representative , Mt. Joy, PA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8559-3674","authenticated-orcid":false,"given":"Barbara","family":"Horvath","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Medical Center Groningen, University of Groningen , Groningen , the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0712-2540","authenticated-orcid":false,"given":"Gregor B","family":"Jemec","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Zealand University Hospital , Roskilde , Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7596-892X","authenticated-orcid":false,"given":"Brian","family":"Kirby","sequence":"additional","affiliation":[{"name":"Charles Department of Dermatology, St. Vincent\u2019s University Hospital , Dublin , Ireland"},{"name":"Charles Institute of Dermatology, University College Dublin , Dublin , Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6741-3796","authenticated-orcid":false,"given":"Joselyn","family":"Kirby","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Penn State Health Milton S. Hershey Medical Center , Hershey, PA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4256-478X","authenticated-orcid":false,"given":"Michelle A","family":"Lowes","sequence":"additional","affiliation":[{"name":"The Rockefeller University , New York, NY , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1378-1590","authenticated-orcid":false,"given":"Antonio","family":"Martorell","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Hospital of Manises , Valencia , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6995-7714","authenticated-orcid":false,"given":"Barry M","family":"McGrath","sequence":"additional","affiliation":[{"name":"Patient Representative, HS Ireland , County Clare , Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haley B","family":"Naik","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of California San Francisco , San Francisco, CA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7607-3124","authenticated-orcid":false,"given":"Hazel H","family":"Oon","sequence":"additional","affiliation":[{"name":"Department of Dermatology, National Skin Centre , Singapore, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8158-660X","authenticated-orcid":false,"given":"Errol","family":"Prens","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Erasmus University Medical Center , Rotterdam , the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3201-4637","authenticated-orcid":false,"given":"Christopher J","family":"Sayed","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of North Carolina at Chapel Hill , Chapel Hill, NC , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3734-9607","authenticated-orcid":false,"given":"Linnea","family":"Thorlacius","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Zealand University Hospital , Roskilde , Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hessel H","family":"Van der Zee","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Erasmus University Medical Center , Rotterdam , the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bente","family":"Villumsen","sequence":"additional","affiliation":[{"name":"Patient Representative, The Patients\u2019 Association HS Denmark , Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5257-1142","authenticated-orcid":false,"given":"John R","family":"Ingram","sequence":"additional","affiliation":[{"name":"Department of Dermatology & Academic Wound Healing, Division of Infection and Immunity, Cardiff University , Cardiff , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,11,17]]},"reference":[{"key":"2024090210042952200_ljad454-B1","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jaad.2019.08.090","article-title":"Hidradenitis suppurativa: epidemiology, clinical presentation, and pathogenesis","volume":"82","author":"Goldburg","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"2024090210042952200_ljad454-B2","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1016\/j.jid.2018.06.171","article-title":"Women with hidradenitis suppurativa have an elevated risk of suicide","volume":"138","author":"Tiri","year":"2018","journal-title":"J Invest Dermatol"},{"key":"2024090210042952200_ljad454-B3","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/jdv.16677","article-title":"Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life","volume":"35","author":"Nguyen","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2024090210042952200_ljad454-B4","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph18116131","article-title":"Quality of life in hidradenitis suppurativa: an update","volume":"18","author":"Chernyshov","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"2024090210042952200_ljad454-B5","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1001\/jamadermatol.2021.1677","article-title":"Prevalence of hidradenitis suppurativa: a systematic review and meta-regression analysis","volume":"157","author":"Jfri","year":"2021","journal-title":"JAMA Dermatol"},{"key":"2024090210042952200_ljad454-B6","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/bjd.16101","article-title":"Population-based Clinical Practice Research Datalink study using algorithm modelling to identify the true burden of hidradenitis suppurativa","volume":"178","author":"Ingram","year":"2018","journal-title":"Br J Dermatol"},{"key":"2024090210042952200_ljad454-B7","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/bjd.19435","article-title":"The epidemiology of hidradenitis suppurativa","volume":"183","author":"Ingram","year":"2020","journal-title":"Br J Dermatol"},{"key":"2024090210042952200_ljad454-B8","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1111\/bjd.19210","article-title":"The prevalence of hidradenitis suppurativa is shown by the Secure Anonymised Information Linkage (SAIL) Databank to be one per cent of the population of Wales","volume":"183","author":"Ingram","year":"2020","journal-title":"Br J Dermatol"},{"key":"2024090210042952200_ljad454-B9","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0190-9622(96)90321-7","article-title":"The prevalence of hidradenitis suppurativa and its potential precursor lesions","volume":"35","author":"Jemec","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"2024090210042952200_ljad454-B10","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1111\/bjd.13163","article-title":"The Hidradenitis Suppurativa Priority Setting Partnership","volume":"171","author":"Ingram","year":"2014","journal-title":"Br J Dermatol"},{"key":"2024090210042952200_ljad454-B11","first-page":"7","article-title":"The role of medical registries, potential applications and limitations","volume":"92","author":"Pop","year":"2019","journal-title":"Med Pharm Rep"},{"key":"2024090210042952200_ljad454-B12","first-page":"142","article-title":"Evaluation and implementation of public health registries","volume":"106","author":"Solomon","year":"1991","journal-title":"Public Health Rep"},{"issue":"S1","key":"2024090210042952200_ljad454-B13","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/exd.14610","article-title":"Registries, multicentre and genome-wide association studies in hidradenitis suppurativa","volume":"31","author":"Jemec","year":"2022","journal-title":"Exp Dermatol"},{"key":"2024090210042952200_ljad454-B14","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1001\/jamadermatol.2019.3652","article-title":"Creation of a registry to address knowledge gaps in hidradenitis suppurativa and pregnancy \u2013 reply","volume":"156","author":"Naik","year":"2020","journal-title":"JAMA Dermatol"},{"key":"2024090210042952200_ljad454-B15","doi-asserted-by":"crossref","first-page":"e274-6","DOI":"10.1111\/jdv.17023","article-title":"European registry for hidradenitis suppurativa: state of play","volume":"35","author":"Daxhelet","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2024090210042952200_ljad454-B16","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1001\/jamadermatol.2019.1105","article-title":"A call to accelerate hidradenitis suppurativa research and improve care \u2013 moving beyond burden","volume":"155","author":"Naik","year":"2019","journal-title":"JAMA Dermatol"},{"key":"2024090210042952200_ljad454-B17","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1001\/jamadermatol.2019.4162","article-title":"Creation of a registry to address knowledge gaps in hidradenitis suppurativa and pregnancy","volume":"156","author":"Adelekun","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"Suppl. 3","key":"2024090210042952200_ljad454-B18","article-title":"Methodological guidelines and recommendations for efficient and rational governance of patient registries","volume":"25","author":"Zaletel","year":"2015","journal-title":"Eur J Public Health"},{"key":"2024090210042952200_ljad454-B19","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/bjd.16672","article-title":"A core domain set for hidradenitis suppurativa trial outcomes: an international Delphi process","volume":"179","author":"Thorlacius","year":"2018","journal-title":"Br J Dermatol"},{"key":"2024090210042952200_ljad454-B20","doi-asserted-by":"crossref","first-page":"e1000393","DOI":"10.1371\/journal.pmed.1000393","article-title":"Using the Delphi technique to determine which outcomes to measure in clinical trials: recommendations for the future based on a systematic review of existing studies","volume":"8","author":"Sinha","year":"2011","journal-title":"PLoS Med"},{"key":"2024090210042952200_ljad454-B21","doi-asserted-by":"crossref","first-page":"e449\u201358","DOI":"10.1111\/ijd.15579","article-title":"Hidradenitis suppurativa: pathogenesis, clinical presentation, epidemiology, and comorbid associations","volume":"60","author":"Preda-Naumescu","year":"2021","journal-title":"Int J Dermatol"},{"key":"2024090210042952200_ljad454-B22","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.jaad.2014.09.012","article-title":"Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: a chart-verified case\u2013control analysis","volume":"71","author":"Shlyankevich","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"2024090210042952200_ljad454-B23","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"key":"2024090210042952200_ljad454-B24","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2340\/00015555-2513","article-title":"Hurley staging refined: a proposal by the Dutch Hidradenitis Suppurativa Expert Group","volume":"97","author":"Horv\u00e1th","year":"2017","journal-title":"Acta Derm Venereol"},{"key":"2024090210042952200_ljad454-B25","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/bjd.21236","article-title":"Development and initial validation of the HS-IGA: a novel hidradenitis suppurativa-specific investigator global assessment for use in interventional trials","volume":"187","author":"Garg","year":"2022","journal-title":"Br J Dermatol"},{"key":"2024090210042952200_ljad454-B26","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/bjd.18692","article-title":"The Hidradenitis Suppurativa Quality of Life (HiSQOL) score: development and validation of a measure for clinical trials","volume":"183","author":"Kirby","year":"2020","journal-title":"Br J Dermatol"},{"key":"2024090210042952200_ljad454-B27","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/bjd.19344","article-title":"Validation of global item for assessing impact on quality of life of patients with hidradenitis suppurativa","volume":"184","author":"Kirby","year":"2021","journal-title":"Br J Dermatol"},{"key":"2024090210042952200_ljad454-B28","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1080\/03007995.2021.1927689","article-title":"The multiple stakeholder approach to real-world evidence (RWE) generation: observing multidisciplinary expert consensus on quality indicators of rare disease patient registries (RDRs)","volume":"37","author":"Jandhyala","year":"2021","journal-title":"Curr Med Res Opin"},{"key":"2024090210042952200_ljad454-B29","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jclinepi.2023.03.022","article-title":"Patient participation impacts outcome domain selection in core outcome sets for research: an updated systematic review","volume":"158","author":"Dodd","year":"2023","journal-title":"J Clin Epidemiol"},{"key":"2024090210042952200_ljad454-B30","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/bjd.21277","article-title":"The Eumelanin Human Skin Colour Scale: a proof-of-concept study","volume":"187","author":"Dadzie","year":"2022","journal-title":"Br J Dermatol"},{"key":"2024090210042952200_ljad454-B31","doi-asserted-by":"crossref","first-page":"310","DOI":"10.36849\/JDD.7087","article-title":"Skin of color representation in clinical trials: an analysis of ClinicalTrials.gov from 2008\u20132022","volume":"22","author":"Jacobs","year":"2023","journal-title":"J Drugs Dermatol"},{"key":"2024090210042952200_ljad454-B32","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jaad.2017.02.005","article-title":"Incidence of hidradenitis suppurativa in the United States: a sex- and age-adjusted population analysis","volume":"77","author":"Garg","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"S1","key":"2024090210042952200_ljad454-B33","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/exd.14341","article-title":"Hidradenitis suppurativa in skin of colour","volume":"30","author":"Zouboulis","year":"2021","journal-title":"Exp Dermatol"},{"key":"2024090210042952200_ljad454-B34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jdin.2020.02.001","article-title":"Hidradenitis suppurativa prevalence in Berekum, Ghana: a cross-sectional study and initial validation of a questionnaire in an African setting","volume":"1","author":"Hagan","year":"2020","journal-title":"JAAD Int"},{"key":"2024090210042952200_ljad454-B35","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/exd.14214","article-title":"What causes hidradenitis suppurativa? \u2013 \u200c15\u2005years after","volume":"29","author":"Zouboulis","year":"2020","journal-title":"Exp Dermatol"},{"key":"2024090210042952200_ljad454-B36","article-title":"Can we improve prognosis in hidradenitis suppurativa? Identifying patients in the window of opportunity","author":"Melgosa Ramos","year":"2023","journal-title":"Actas Dermosifiliogr"},{"key":"2024090210042952200_ljad454-B37","doi-asserted-by":"crossref","first-page":"e42\u20133","DOI":"10.1111\/bjd.15842","article-title":"A pilot study of fatigue in patients with hidradenitis suppurativa","volume":"178","author":"Riis","year":"2018","journal-title":"Br J Dermatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjd\/advance-article-pdf\/doi\/10.1093\/bjd\/ljad454\/56446874\/ljad454.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/190\/4\/510\/58993223\/ljad454.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/190\/4\/510\/58993223\/ljad454.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T12:42:01Z","timestamp":1725280921000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/190\/4\/510\/7425603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,17]]},"references-count":37,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,11,17]]},"published-print":{"date-parts":[[2024,3,15]]}},"URL":"https:\/\/doi.org\/10.1093\/bjd\/ljad454","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,4]]},"published":{"date-parts":[[2023,11,17]]}}}